These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26637806)

  • 21. Epithelial-to-mesenchymal transition in paired human primary and recurrent glioblastomas.
    Kubelt C; Hattermann K; Sebens S; Mehdorn HM; Held-Feindt J
    Int J Oncol; 2015; 46(6):2515-25. PubMed ID: 25845427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary glioblastomas with and without EGFR amplification: relationship to genetic alterations and clinicopathological features.
    Benito R; Gil-Benso R; Quilis V; Perez M; Gregori-Romero M; Roldan P; Gonzalez-Darder J; Cerdá-Nicolas M; Lopez-Gines C
    Neuropathology; 2010 Aug; 30(4):392-400. PubMed ID: 20051017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telomerase activity in primary and secondary glioblastomas multiforme as a novel molecular tumor marker.
    Harada K; Kurisu K; Tahara H; Tahara E; Ide T; Tahara E
    J Neurosurg; 2000 Oct; 93(4):618-25. PubMed ID: 11014540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma.
    Saidi A; Javerzat S; Bellahcène A; De Vos J; Bello L; Castronovo V; Deprez M; Loiseau H; Bikfalvi A; Hagedorn M
    Int J Cancer; 2008 May; 122(10):2187-98. PubMed ID: 18092325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets.
    Hoelzinger DB; Mariani L; Weis J; Woyke T; Berens TJ; McDonough WS; Sloan A; Coons SW; Berens ME
    Neoplasia; 2005 Jan; 7(1):7-16. PubMed ID: 15720813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary glioblastomas express mesenchymal stem-like properties.
    Tso CL; Shintaku P; Chen J; Liu Q; Liu J; Chen Z; Yoshimoto K; Mischel PS; Cloughesy TF; Liau LM; Nelson SF
    Mol Cancer Res; 2006 Sep; 4(9):607-19. PubMed ID: 16966431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of dysregulated long non-coding RNA expressions in glioblastoma cells.
    Balci T; Yilmaz Susluer S; Kayabasi C; Ozmen Yelken B; Biray Avci C; Gunduz C
    Gene; 2016 Sep; 590(1):120-2. PubMed ID: 27306825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of genes with increased expression in human glioblastomas.
    Kavsan V; Shostak K; Dmitrenko V; Zozulya Y; Rozumenko V; Demotes-Mainard J
    Tsitol Genet; 2005; 39(6):37-49. PubMed ID: 16396319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent gene amplification and overexpression of decoy receptor 3 in glioblastoma.
    Arakawa Y; Tachibana O; Hasegawa M; Miyamori T; Yamashita J; Hayashi Y
    Acta Neuropathol; 2005 Mar; 109(3):294-8. PubMed ID: 15627206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
    Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
    J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anatomical localization of p53 mutated tumors: A radiographic study of human glioblastomas.
    Zhang T; Wang Y; Fan X; Ma J; Li S; Jiang T; Wang L
    J Neurol Sci; 2014 Nov; 346(1-2):94-8. PubMed ID: 25130928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GPR26: a marker for primary glioblastoma?
    Carter AN; Cole CL; Playle AG; Ramsay EJ; Shervington AA
    Mol Cell Probes; 2008 Apr; 22(2):133-7. PubMed ID: 18037267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria.
    Günther HS; Schmidt NO; Phillips HS; Kemming D; Kharbanda S; Soriano R; Modrusan Z; Meissner H; Westphal M; Lamszus K
    Oncogene; 2008 May; 27(20):2897-909. PubMed ID: 18037961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.
    Beier D; Hau P; Proescholdt M; Lohmeier A; Wischhusen J; Oefner PJ; Aigner L; Brawanski A; Bogdahn U; Beier CP
    Cancer Res; 2007 May; 67(9):4010-5. PubMed ID: 17483311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular genetic analysis of deep-seated glioblastomas.
    Hayashi Y; Yamashita J; Watanabe T
    Cancer Genet Cytogenet; 2004 Aug; 153(1):64-8. PubMed ID: 15325097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct transcription profiles of primary and secondary glioblastoma subgroups.
    Tso CL; Freije WA; Day A; Chen Z; Merriman B; Perlina A; Lee Y; Dia EQ; Yoshimoto K; Mischel PS; Liau LM; Cloughesy TF; Nelson SF
    Cancer Res; 2006 Jan; 66(1):159-67. PubMed ID: 16397228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
    Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
    J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma.
    Tepel M; Roerig P; Wolter M; Gutmann DH; Perry A; Reifenberger G; Riemenschneider MJ
    Int J Cancer; 2008 Nov; 123(9):2080-6. PubMed ID: 18709645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extent of tumor removal and molecular markers in cerebral glioblastoma: a combined prognostic factors study in a surgical series of 105 patients.
    Salvati M; Pichierri A; Piccirilli M; Floriana Brunetto GM; D'Elia A; Artizzu S; Santoro F; Arcella A; Giangaspero F; Frati A; Simione L; Santoro A
    J Neurosurg; 2012 Aug; 117(2):204-11. PubMed ID: 22655594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.